Diane Weiser | VP, IR & Corporate Communications |
Robert Wong | VP & CAO |
Fady Malik | EVP, Research & Development |
Andrew Wolff | SVP, Senior Fellow, Clinical Research & Development |
Robert Blum | CEO, President & Director |
Ching Jaw | SVP & CFO |
Jason Butler | JMP Securities |
Joseph Pantginis | H.C. Wainwright & Co. |
Chad Messer | Needham & Company |
Jeff Hung | Morgan Stanley |
Edward Tenthoff | Piper Sandler & Co. |
Good afternoon and welcome, ladies and gentlemen, to Cytokinetics' Fourth Quarter 2019 Conference Call. At this time, I'd like to inform you that this call is being recorded. [Operator Instructions].
I'll now turn the call over to Diane Weiser, Cytokinetics' Vice President of Corporate Communications and Investor Relations. Please go ahead.